Free EU-Wide Shipping on Orders Over €200
This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals.
Ipamorelin
40,00 €
Ipamorelin is a selective growth hormone secretagogue pentapeptide. Researched for targeted GH release without significant effects on cortisol, prolactin, or appetite. 10mg lyophilized powder, ≥99% purity.
Bulk Discounts
- Buy 3+ for 38,00 € each and save 5%
- Buy 5+ for 36,00 € each and save 10%
- Buy 10+ for 34,00 € each and save 15%
Ships Tomorrow - order cutoff passed
Free EU Shipping on orders over €200
Third party tested
Ipamorelin—
40,00 €
Advanced Laboratory Testing
HPLC
Mass Spec
≥99% Purity
Secure
Fast Ship
EU Based
Characteristics
| Molecular Formula | C38H49N9O5 |
| CAS | 170851-70-4 |
| Molar Mass | 711.85 g/mol |
| Amino Acid Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Synonyms | NNC 26-0161, Ipamorelin acetate |
| Solubility | Soluble in water |
| Organoleptic Profile | White powder |
| Physical Form | Lyophilized powder |
How does Ipamorelin work?
Ipamorelin is a pentapeptide growth hormone secretagogue that selectively binds the ghrelin/GHS receptor (GHSR) to stimulate growth hormone release from the anterior pituitary.
Unlike other GH secretagogues such as GHRP-6 and GHRP-2, Ipamorelin demonstrates high selectivity — it stimulates GH release in a dose-dependent manner without significantly affecting cortisol, prolactin, FSH, LH, or TSH levels. This selectivity makes it valuable for studying isolated GH axis function.
Ipamorelin preserves the natural pulsatile pattern of GH release rather than creating a sustained elevation. Research indicates it does not significantly increase appetite (unlike ghrelin and GHRP-6), making it a cleaner pharmacological tool for GH research.
References
- 1Raun K, et al. "Ipamorelin, the first selective growth hormone secretagogue" European Journal of Endocrinology. 1998. doi:10.1530/eje.0.1390552
- 2Johansen PB, et al. "Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats" Growth Hormone & IGF Research. 1999. doi:10.1054/ghir.1999.9998
- 3Beck DE, et al. "Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for postoperative ileus" Journal of Gastrointestinal Surgery. 2014. doi:10.1007/s11605-014-2524-y
Resource
All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration or the European Medicines Agency. Products are not intended to diagnose, treat, cure, or prevent any disease.
